These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1150039)

  • 1. Isoniazid-associated hepatitis in 114 patients.
    Black M; Mitchell JR; Zimmerman HJ; Ishak KG; Epler GR
    Gastroenterology; 1975 Aug; 69(2):289-302. PubMed ID: 1150039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.
    Bailey WC; Taylor SL; Dascomb HE; Greenberg HB; Ziskind MM
    Am Rev Respir Dis; 1973 Apr; 107(4):523-9. PubMed ID: 4697661
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoniazid hepatitis.
    Maddrey WC; Boitnott JK
    Ann Intern Med; 1973 Jul; 79(1):1-12. PubMed ID: 4721174
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.
    Kopanoff DE; Snider DE; Caras GJ
    Am Rev Respir Dis; 1978 Jun; 117(6):991-1001. PubMed ID: 666111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine-associated hepatic injury.
    van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
    J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Kwo PY; Cohen SM; Lim JK
    Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
    Mitchell JR; Zimmerman HJ; Ishak KG; Thorgeirsson UP; Timbrell JA; Snodgrass WR; Nelson SD
    Ann Intern Med; 1976 Feb; 84(2):181-92. PubMed ID: 766682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxicillin-Clavulanate-Induced Liver Injury.
    deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
    Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy.
    Mitchell JR; Long MW; Thorgeirsson UP; Jollow DJ
    Chest; 1975 Aug; 68(2):181-90. PubMed ID: 1080096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of supplementation with Scutellaria baicalensis on hepatic function.
    Puri BK; White N; Monro JA
    Med Hypotheses; 2019 Dec; 133():109402. PubMed ID: 31557595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid-associated hepatitis. Report of an outbreak.
    Garibaldi RA; Drusin RE; Ferebee SH; Gregg MB
    Am Rev Respir Dis; 1972 Sep; 106(3):357-65. PubMed ID: 5080707
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases.
    Lewis JH; Zimmerman HJ; Benson GD; Ishak KG
    Gastroenterology; 1984 Mar; 86(3):503-13. PubMed ID: 6319220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.
    Scharer L; Smith JP
    Ann Intern Med; 1969 Dec; 71(6):1113-20. PubMed ID: 5361410
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoniazid hepatitis in adolescents.
    Litt IF; Cohen MI; McNamara H
    J Pediatr; 1976 Jul; 89(1):133-5. PubMed ID: 819639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotective activity of melittin on isoniazid- and rifampicin-induced liver injuries in male albino rats.
    Naji KM; Al-Khatib BY; Al-Haj NS; D'souza MR
    BMC Pharmacol Toxicol; 2021 Jul; 22(1):39. PubMed ID: 34217369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin.
    Tsagaropoulou-Stinga H; Mataki-Emmanouilidou T; Karida-Kavalioti S; Manios S
    Pediatr Infect Dis; 1985; 4(3):270-3. PubMed ID: 4000989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of hepatic injury induced by methyldopa.
    Seggie J; Saunders SJ; Kirsch RE; Campbell JA; Gitlin N; Clain D; Terblanche J
    S Afr Med J; 1979 Jan; 55(3):75-83. PubMed ID: 424937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury.
    Wang C; Fan RQ; Zhang YX; Nie H; Li K
    World J Gastroenterol; 2016 Nov; 22(44):9775-9783. PubMed ID: 27956801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
    Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
    Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.